MYRIAD GENETICS, INC. (MYGN) Free cash flow 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.8MFY2025 · since FY2016: $100.1M → -$13.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.8M | +50.2% |
| FY2024 | -$27.7M | +84.1% |
| FY2023 | -$174.1M | -14.8% |
| FY2022 | -$151.6M | -25366.7% |
| FY2021 | $600,000 | — |
| FY2019 | $50.5M | -32.8% |
| FY2018 | $75.1M | -30.1% |
| FY2017 | $107.5M | +7.4% |
| FY2016 | $100.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice